NCT00049101View on ClinicalTrials.gov

Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2002

Study Completion Date

August 31, 2004

Conditions
Colorectal Cancer
Interventions
DRUG

erlotinib hydrochloride

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00049101 - Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter